Dr. Tahseen Mozaffar is a board-certified neurologist who specialize in neuromuscular disorders and directs the UCI Health ALS & Neuromuscular Center.
His clinical focus includes amyotrophic lateral sclerosis (ALS), myasthenia gravis, inflammatory myopathies, Pompe disease, muscle pathology and all types of muscular dystrophies.
Mozaffar earned his medical degree at the Aga Khan University in Karachi, Pakistan, where he completed a rotating internship in internal medicine and general surgery. He completed a neurology residency at Barnes-Jewish Hospital in St. Louis, Mo., followed by a fellowship in neuromuscular disorders at Washington University, also in St. Louis.
After a three-year faculty appointment at the Aga Khan University, Mozaffar joined the UCI School of Medicine as an assistant professor and director of UCI Health neuromuscular services, which has become a nationally recognized clinical and research program. The ALS & Neuromuscular Center is one of only six Muscular Dystrophy Association-designated centers in California, a recognition of our advances in the diagnosis and treatment of disorders affecting the nerves, muscles and neuromuscular junction.
Mozaffar's research focus includes clinical and translational studies of neuromuscular disorders. He is the principal site investigator of more than a dozen clinical trials for myasthenia gravis, immune myopathies and rare and ultra-rare myopathies. He is also the lead UCI investigator for NeuroNEXT, a collaborative national effort to help streamline Phase 2 clinical trials for brain disorders that is supported by the National Institute of Neurological Disorders and Stroke (NINDS).
As an expert in rare and ultra-rare myopathies, Mozaffar advises many pharmaceutical companies on clinical trial design and the identification of disease targets. He serves on a Pompe disease advisory board for Amicus Therapeutics and Spark Therapeutics, as well as on the data safety monitoring board for Acceleron and Sarepta Therapeutics. He also is a reviewer for the National Institutes of Health's Emerging Technologies and Training in Neurosciences (ETTN) group. He has co-authored more than 175 peer-reviewed publications and has written or co-written more than a dozen book chapters and reviews.
He sees patients at the ALS & Neuromuscular Center in Orange.
View this physician's faculty profile ›
Speakers Bureau Topics
- Amyotrophic Lateral Sclerosis (ALS), current knowledge
- Diabetic Neuropathies Update
- Electrodiagnostic Techniques in Orthopaedics, ENT and Rehab Medicine
- Guillain-Barre Syndromes and Chronic Inflammatory Demyelinating Polyneuropathies (CIDP)
- Immune-Mediated Myopathies: An Update
- Immune-Mediated Neuropathies Update
- Intravenous Immunoglobulin (IVIG), Uses and Abuses in Neurological Disorders
- Muscular Dystrophies
- Myasthenia Gravis, Management and Diagnosis
- Neuromuscular Diseases Update